Indivior PLC (LON:INDV – Get Free Report)’s stock price crossed below its 200-day moving average during trading on Friday . The stock has a 200-day moving average of GBX 840.40 ($10.57) and traded as low as GBX 659.50 ($8.29). Indivior shares last traded at GBX 699.50 ($8.80), with a volume of 893,588 shares traded.
Wall Street Analyst Weigh In
Separately, Jefferies Financial Group reiterated a “buy” rating and set a GBX 1,800 ($22.64) price target on shares of Indivior in a research note on Tuesday, December 17th.
Read Our Latest Stock Analysis on INDV
Indivior Price Performance
Indivior Company Profile
Indivior PLC, together with its subsidiaries, engages in the development, manufacture, and sale of buprenorphine-based prescription drugs for the treatment of opioid dependence and co-occurring disorders in the United States, the United Kingdom, and internationally. The company develops medicines to treat substance use disorders, serious mental illnesses, and opioid overdose.
See Also
- Five stocks we like better than Indivior
- Growth Investing: Should You Adopt This Investing Strategy in 2022?
- Chaos and Cash: Finding Opportunity in Volatility
- Compound Interest and Why It Matters When Investing
- Realty Income: An Anchor in Volatile Markets
- How to Profit From Growth Investing
- Autodesk Designs Value for Investors: Uptrend Set to Continue
Receive News & Ratings for Indivior Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Indivior and related companies with MarketBeat.com's FREE daily email newsletter.